Skip to main content

A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

Abstract

Introduction

Oral mucositis (OM) is a significant early complication of hematopoietic cell transplantation (HCT). This phase III randomized double-blind placebo-controlled study was designed to compare the ability of 2 different low level GaAlAs diode lasers (650 nm and 780 nm) to prevent oral mucositis in HCT patients conditioned with chemotherapy or chemoradiotherapy.

Materials and methods

Seventy patients were enrolled and randomized into 1 of 3 treatment groups: 650 nm laser, 780 nm laser or placebo. All active laser treatment patients received daily direct laser treatment to the lower labial mucosa, right and left buccal mucosa, lateral and ventral surfaces of the tongue, and floor of mouth with energy densities of 2 J/cm2. Study treatment began on the first day of conditioning and continued through day +2 post HCT. Mucositis and oral pain was measured on days 0, 4, 7, 11, 14, 18, and 21 post HCT.

Results

The 650 nm wavelength reduced the severity of oral mucositis and pain scores. Low level laser therapy was well-tolerated and no adverse events were noted.

Discussion

While these results are encouraging, further study is needed to truly establish the efficacy of this mucositis prevention strategy. Future research needs to determine the effects of modification of laser parameters (e.g., wavelength, fluence, repetition rate of energy delivery, etc.) on the effectiveness of LLE laser to prevent OM.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Bellm LA, Epstein JB, Rose-Ped A et al (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33–39

    PubMed  CAS  Google Scholar 

  2. 2.

    Stiff P (2001) Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 27(Suppl 2):S3–S11

    PubMed  Article  Google Scholar 

  3. 3.

    Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem cell transplantation. J Clin Oncol 19:2201–2205

    PubMed  CAS  Google Scholar 

  4. 4.

    Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(Supp 9):1995–2025

    PubMed  Article  Google Scholar 

  5. 5.

    Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J et al (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(Supp 9):2026–2046

    PubMed  Article  Google Scholar 

  6. 6.

    Schubert, MM, Williams B, Lloid ME, Donaldson G, Chapko MK (1992) Clinical assessment for the rating of oral mucosal changes associated with bone marrow transplantation: development of an oral mucositis index. Cancer 69:2469–2477

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Kolbinson DA, Schubert MM, Flournoy N, Truelove EL (1988) Early oral changes following bone marrow transplantation. Oral Surg Oral Med Oral Pathol 66:130–138

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    Chapko MK, Syrjala KL, Schilter L, Cummings C, Sullivan KM (1989) Chemotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea. Bone Marrow Transplant 4:181–186

    PubMed  CAS  Google Scholar 

  9. 9.

    Chapko MK, Syrjala KL, Bush N, Jedlow C, Yanke MR (1991) Development of a behavioral measure of mouth pain, nausea, and wellness for patients receiving radiation and chemotherapy. J Pain Symptom Manage 6:15–23

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Bearman SI, Applebaum FR, Buckner CD et al (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6:1562–1568

    PubMed  CAS  Google Scholar 

  11. 11.

    Chapko NK, Syrjala KL, Schilter L et al (1989) Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea. Bone Marrow Transplant 4:181–186

    PubMed  CAS  Google Scholar 

  12. 12.

    Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R et al (2000) Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 110:292–299

    PubMed  Article  CAS  Google Scholar 

  13. 13.

    Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4:227–284

    Article  CAS  Google Scholar 

  14. 14.

    Blijlevens NMA, Donnelly JP, De Pauw BE (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25:1269–1278

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Tardieu C, Cowen D, Thirion, X, Franquin JC (1996) Quantitative scale of oral mucositis associated with autologous bone marrow transplantation. Eur J Cancer 32:381–387

    Google Scholar 

  16. 16.

    Epstein JB, Schubert MM (2003) Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology (Williston Park) 17:1767–1779 (discussion 1779–1782, 1791–1792)

    Google Scholar 

  17. 17.

    Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590–2598

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Schubert MM, Franquin JC, Niccoli-Filho, Marical F, Lloid M, Kelly J (1997) Effects of low-energy laser on oral mucositis: a phase I/II pilot study. Cancer Res Wkly 7:14

    Google Scholar 

  19. 19.

    Barasch A, Peterson DE, Tanzer JM, D’Ambrosio JA, Nuki K, Schubert MM et al (1995) Helium–neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients. Cancer 76:2550–2556

    PubMed  Article  CAS  Google Scholar 

  20. 20.

    Cowen D, Tardieu C, Schubert MM, Peterson D, Resbeut M, Faucher C et al (1997) Low energy HeNe laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 38:697–703

    PubMed  Article  CAS  Google Scholar 

  21. 21.

    Bensadoun RJ, Franquin JC, Ciais G, Carcout V, Schubert MM, Viot M et al (1999) Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer. Support Care Cancer 7:244–252

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    Migliorati C, Massumoto C, Eduardo FP, Muller KP, Carrieri T, Haypek P et al (2001) Low-energy laser therapy in oral mucositis. Science 1:97–100

    Google Scholar 

  23. 23.

    Bensadoun RJ, Ciais G (2002) Radiation and chemotherapy-induced mucositis in oncology: results of multicenter phase III studies. The Journal of Oral Laser Applications 2:115–120

    Google Scholar 

  24. 24.

    Wong SF, Wilder-Smith P (2002) Pilot study of laser effects on oral mucositis in patients receiving chemotherapy. Cancer J 8:247–254

    PubMed  Article  Google Scholar 

  25. 25.

    Nes AG, Posso MB (2005) Patients with moderate chemotherapy-induced mucositis: pain therapy using low intensity lasers. Int Nurs Rev 52:68–72

    PubMed  Article  CAS  Google Scholar 

  26. 26.

    Arun Maiya G, Sagar MS, Fernandes D (2006) Effect of low level helium–neon (He–Ne) laser therapy in the prevention & treatment of radiation induced mucositis in head & neck cancer patients. Indian J Med Res 124(4):399–402

    PubMed  CAS  Google Scholar 

  27. 27.

    Antunes HS, de Azevedo AM, da Silva Bouzas LF et al (2006) Low power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 109:2250–2255

    PubMed  Article  CAS  Google Scholar 

  28. 28.

    Genot MT, Klastersky J (2005) Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy. Curr Opin Oncol 17:236–240

    PubMed  Article  Google Scholar 

  29. 29.

    Braverman B, McCarthy R, Ivankovich AD, Forde DE, Overfield M, Bapna MS (1989) Effect of HeNe and infrared laser irradiation on wound healing in rabbits. Lasers Surg Med 9:50–58

    PubMed  Article  CAS  Google Scholar 

  30. 30.

    Boratoletto R, Silva NS, Zangaro RA et al (2004) Mitochondrial membrane potential after low-power laser irradiation. Lasers Med Sci 18:204–206

    Article  Google Scholar 

  31. 31.

    Loevshall H, Arenholt-Bindslev D (1994) Effect of low level diode irradiation of human oral mucous fibroblasts in vitro. Lasers Surg Med 59:167–170

    Google Scholar 

  32. 32.

    Almeida-Lopes L, Rigau J, Zangaro RA, Guidugli-Neto J, Jaeger MM (2001) Comparison of the low level laser therapy effects on cultured human gingival fibroblasts proliferation using different irradiance and same fluence. Lasers Surg Med 29:179–184

    PubMed  Article  CAS  Google Scholar 

  33. 33.

    Pereira AN, Eduardo CP, Matson E, Marques MM (2002) Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med 31:263–267

    PubMed  Article  Google Scholar 

  34. 34.

    Marques MM, Pereira NA, Fujihara NA, Nogueira FN, Eduardo CP (2004) Effect of low-power laser irradiation on protein synthesis and ultrastructure of human gingival fibroblasts. Lasers Surg Med 34:260–265

    PubMed  Article  Google Scholar 

  35. 35.

    Sonis ST (2002) The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med 13:380–389

    PubMed  Article  Google Scholar 

  36. 36.

    Sonis ST, Scherer J, Phelan S, Lucey CA, Barron JE, O’Donnell KE et al (2002) The gene expression sequence of radiated mucosa in an animal mucositis model. Cell Prolif 35(Suppl 1):93–102

    PubMed  Article  CAS  Google Scholar 

  37. 37.

    Pereira AN, Eduardo CP, Matson E, Marques MM (2002) Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med 31:263–267

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mark M. Schubert.

Additional information

Jean-Claude Franquin has already retired from the Universite de la Mediterranee.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schubert, M.M., Eduardo, F.P., Guthrie, K.A. et al. A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer 15, 1145–1154 (2007). https://doi.org/10.1007/s00520-007-0238-7

Download citation

Keywords

  • Low level laser
  • Mucositis prevention
  • Hematopoietic cell transplant